CureVac about a year ago opted to focus on oncology when it agreed to sell its remaining influenza and COVID-19 vaccine development to its alliance partner, Britain's GSK
Tata Memorial Centre has tied up with Wipro GE HealthCare Technologies Inc to establish a Cancer Research & Innovation Centre. The collaboration aims to strengthen clinical research and academic engagement activities with the establishment of a 'Joint Working Group' to determine key project areas and a collaboration roadmap for the next five years, Tata Memorial Centre (TMC) said in a statement. "The government is adopting a strategic, policy-driven approach to fight cancer with the establishment of daycare centres, expansion of cancer care ecosystem, promoting cancer screenings and awareness programmes. However, early detection, equitable access and preventive care remain a challenge," Tata Memorial Hospital Director CS Pramesh stated. With Wipro GE HealthCare, TMC aims to enhance clinical research and promote academic engagement to transform personalised cancer care for improved outcomes cancer care, he added. "With this partnership, we strengthen our commitment to connect ...
Dr Reddy's Laboratories on Thursday said it has joined hands with global biotech firm Alvotech to co-develop and commercialise a biosimilar product for treating multiple types of cancer. The Hyderabad-based drug major has entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets, Dr Reddy's Laboratories said in a statement. Keytruda (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were USD 29.5 billion. The collaboration combines Dr Reddy's and Alvotech's proven capabilities in biosimilars thereby speeding up the development process and extending the global reach for this biosimilar candidate, the company noted. Under the terms of the agreement, the parties will be jointly responsible for developing and manufacturing the biosimilar candidate and sharing costs and responsibilities, it stated. Subject to certain ...
Former US President Joe Biden on Friday delivered his first remarks since announcing he had an aggressive form of prostate cancer, speaking in a steady voice during a sombre Memorial Day gathering and later smiling and saying he's "feeling good". Biden spoke at an annual gathering marking Memorial Day at Veterans Memorial Park in his home state of Delaware, not far from his home in Wilmington. The event coincided with the 10th anniversary of his son Beau's death. It also came amid renewed questions about Biden's mental and physical health after the recent publication of a book about his fitness for office. Speaking to reporters after the event, Biden said he was already undergoing treatment for cancer, which entailed taking a pill, he said. The expectation is we're gonna be able to beat this, he said. I'm feeling good. Biden dropped his reelection bid in July 2024 following a disastrous debate against Donald Trump, after which those in his party questioned whether he could continu
New WHO study finds that drinking alcohol, even in small daily amounts, increases the risk of pancreatic cancer, one of the hardest cancers to detect and treat
A sperm donor unknowingly carrying a rare cancer-causing gene mutation fathered 67 children in Europe, with 10 diagnosed with cancer already, prompting urgent calls for limits on use of donor sperm
As Joe Biden begins treatment for prostate cancer, here's a look at other US presidents who faced cancer diagnoses and how their cases were managed
Donald Trump said Joe Biden's aggressive cancer should have been detected earlier and hinted that information was withheld from the public
King Charles, who is also undergoing cancer treatment, privately sent a message of support to Joe Biden after the latter's aggressive prostate cancer diagnosis
Think only smokers get lung cancer? Or that cutting sugar stops cancer growth?
In a medical first, US surgeons removed a spinal tumour through a patient's eye socket, a procedure that is being seen as a new hope for treating complex, hard-to-reach tumours with less risk
World Ovarian Cancer Day 2025: Here are the signs, risks, and life-saving steps to protect yourself from a disease that's often detected too late
Pharma major evaluating opportunities to out-license key cancer asset ISB-2001, deal likely in H1CY25
Sharmila Tagore's cancer was diagnosed in 2023 and removed surgically without chemotherapy, says daughter Soha Ali Khan
Writer and filmmaker Tahira Kashyap revealed her breast cancer has recurred seven years after remission, prompting questions about recurrence, symptoms, and treatment
Industry projections suggest that crowdfunding's growth in healthcare financing could rise to 20-30 per cent
This technology is capable of amplifying immune responses against tumours and infections up to 150-fold
These low-cost, high-impact virus therapies are showing promise in clinical trials in China
CarePal, the parent company of Impact Guru, in its State of Cancer Fundraising Report 2024, revealed that the top 100 cancer campaigns on Impact Guru in FY24 raised an average of Rs 10 lakh each
Val Kilmer, the celebrated actor known for 'Top Gun' and 'Batman Forever', died at 65 in Los Angeles from pneumonia after a long battle with throat cancer